IGC Earnings IGC Pharma, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–48 of 48
| Q2 2026 | 2026-06-30 | -0.03 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.02 | 2026-05-15 | 10-Q |
| Q2 2026 | 2025-09-30 | -0.02 | 2025-11-14 | 10-Q |
| Q1 2026 | 2025-06-30 | -0.02 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.02 | — | — |
| FY 2025 | 2025-03-31 | -0.09 | 2025-06-27 | 10-K |
| Q3 2025 | 2024-12-31 | -0.02 | 2025-02-14 | 10-Q |
| Q2 2025 | 2024-09-30 | -0.02 | 2024-11-12 | 10-Q |
| Q1 2025 | 2024-06-30 | -0.03 | — | — |
| FY 2024 | 2024-03-31 | -0.22 | — | — |
| Q3 2024 | 2023-12-31 | -0.09 | — | — |
| Q2 2024 | 2023-09-30 | -0.05 | — | — |
| Q3 2018 | 2017-12-31 | -0.02 | 2018-02-20 | 10-Q |
| Q2 2018 | 2017-09-30 | -0.01 | 2017-11-17 | 10-Q |
| Q1 2018 | 2017-06-30 | -0.02 | 2017-08-18 | 10-Q |
| Q4 2017 (derived) | 2017-03-31 | -0.03 | 2017-07-14 | 10-K |
| FY 2017 | 2017-03-31 | -0.07 | 2017-07-14 | 10-K |
| Q3 2017 | 2016-12-31 | 0.00 | 2017-02-21 | 10-Q |
| Q2 2017 | 2016-09-30 | -0.02 | 2016-11-21 | 10-Q |
| Q1 2017 | 2016-06-30 | -0.02 | 2016-08-16 | 10-Q |
| Q4 2016 (derived) | 2016-03-31 | -0.08 | 2016-07-14 | 10-K |
| FY 2016 | 2016-03-31 | -0.17 | 2016-07-14 | 10-K |
| Q3 2016 | 2015-12-31 | -0.02 | 2016-02-16 | 10-Q |
| Q2 2016 | 2015-09-30 | -0.04 | 2015-11-13 | 10-Q |
| Q1 2016 | 2015-06-30 | -0.03 | 2015-08-14 | 10-Q |
| Q4 2015 (derived) | 2015-03-31 | -0.07 | 2015-07-14 | 10-K |
| FY 2015 | 2015-03-31 | -0.31 | 2015-07-14 | 10-K |
| Q3 2015 | 2014-12-31 | -0.05 | 2015-02-12 | 10-Q |
| Q2 2015 | 2014-09-30 | -0.07 | 2014-11-13 | 10-Q |
| Q1 2015 | 2014-06-30 | -0.12 | 2014-08-14 | 10-Q |
| Q4 2013 (derived) | 2014-03-31 | -0.15 | 2014-07-15 | 10-K |
| FY 2014 | 2014-03-31 | -0.37 | 2014-07-15 | 10-K |
| Q3 2013 | 2013-12-31 | -0.04 | 2014-02-14 | 10-Q |
| Q2 2013 | 2013-09-30 | -0.09 | 2013-11-08 | 10-Q |
| Q1 2013 | 2013-06-30 | -0.09 | 2013-08-16 | 10-Q |
| Q4 2012 (derived) | 2013-03-31 | -0.21 | 2013-07-16 | 10-K |
| FY 2012 | 2013-03-31 | -0.32 | 2013-07-16 | 10-K |
| Q3 2012 | 2012-12-31 | 0.05 | 2013-02-13 | 10-Q |
| Q2 2012 | 2012-09-30 | -0.02 | 2012-11-14 | 10-Q |
| Q1 2012 | 2012-06-30 | -0.14 | — | — |
| Q4 2011 (derived) | 2012-03-31 | -2.13 | 2012-07-16 | 10-K |
| FY 2011 | 2012-03-31 | -2.66 | 2012-07-16 | 10-K |
| Q3 2011 | 2011-12-31 | -0.09 | — | — |
| Q2 2011 | 2011-09-30 | -0.04 | 2011-11-18 | 10-Q |
| Q1 2011 | 2011-06-30 | -0.40 | 2011-08-18 | 10-Q |
| FY 2010 | 2011-03-31 | -13.40 | — | — |
| Q2 2010 | 2010-09-30 | -0.60 | — | — |
| Q1 2010 | 2010-06-30 | -0.50 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.